全文获取类型
收费全文 | 2167篇 |
免费 | 165篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 59篇 |
妇产科学 | 86篇 |
基础医学 | 330篇 |
口腔科学 | 18篇 |
临床医学 | 174篇 |
内科学 | 404篇 |
皮肤病学 | 11篇 |
神经病学 | 362篇 |
特种医学 | 85篇 |
外科学 | 254篇 |
综合类 | 15篇 |
预防医学 | 174篇 |
眼科学 | 21篇 |
药学 | 155篇 |
肿瘤学 | 171篇 |
出版年
2023年 | 18篇 |
2022年 | 35篇 |
2021年 | 73篇 |
2020年 | 37篇 |
2019年 | 45篇 |
2018年 | 66篇 |
2017年 | 60篇 |
2016年 | 48篇 |
2015年 | 53篇 |
2014年 | 61篇 |
2013年 | 100篇 |
2012年 | 141篇 |
2011年 | 165篇 |
2010年 | 102篇 |
2009年 | 75篇 |
2008年 | 103篇 |
2007年 | 137篇 |
2006年 | 107篇 |
2005年 | 104篇 |
2004年 | 113篇 |
2003年 | 73篇 |
2002年 | 95篇 |
2001年 | 35篇 |
2000年 | 26篇 |
1999年 | 32篇 |
1998年 | 12篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 9篇 |
1994年 | 11篇 |
1993年 | 8篇 |
1992年 | 18篇 |
1991年 | 30篇 |
1990年 | 22篇 |
1989年 | 24篇 |
1988年 | 16篇 |
1987年 | 22篇 |
1986年 | 25篇 |
1985年 | 32篇 |
1984年 | 20篇 |
1983年 | 13篇 |
1981年 | 10篇 |
1979年 | 18篇 |
1978年 | 13篇 |
1976年 | 13篇 |
1975年 | 8篇 |
1974年 | 13篇 |
1973年 | 8篇 |
1970年 | 9篇 |
1969年 | 8篇 |
排序方式: 共有2338条查询结果,搜索用时 0 毫秒
1.
2.
3.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485
4.
In brain regions containing noradrenergic (NA) cell bodies or terminals, DSP-4 induces changes in the activity of catecholamine-synthesizing enzymes which suggest that central NA neurons are lesioned by this neurotoxin. In contrast, the lack of change in the same enzymatic activities in an area containing mostly adrenergic (A) neurons (C2 region), favors the hypothesis of a resistance of the A neurons to DSP-4. Furthermore, the enzymatic changes observed in peripheral organs suggest a peripheral activation of the NA cell bodies in response to lesioning of the sympathetic terminals by DSP-4. 相似文献
5.
Nicolas Borenstein Valérie Chetboul Patrick Bruneval Mehrak Hekmati Renaud Tissier Luc Behr Geneviève Derumeaux Didier Montarras 《European journal of cardio-thoracic surgery》2007,31(3):444-451
OBJECTIVE: Cell therapy may be a promising alternative or adjunct to current treatment modalities for ischemic heart failure. But little is known on the impact of myogenic cell transplantation in large animal models of non-ischemic cardiomyopathy. The aim of the present study was to explore whether an ovine model of toxin-induced heart disease could benefit from non-cultured skeletal muscle cell transplantation. METHODS: Sequential intracoronary injections of doxorubicin (0.75 mg/kg) were carried out every 2 weeks until echocardiographic detection of myocardial dysfunction. Sheep were then randomly assigned to either non-cultured cell transplantation (n=8) or placebo injection (n=5). For the cell therapy group, a skeletal muscle biopsy (about 10 g) was explanted from each animal approximately 3h before grafting. After thoracotomy, 20 epicardial injections were carried out. The animals were assessed one last time before sacrifice, 2 months after the thoracotomy. Cells were tracked with cmDiI (red fluorescence) and characterized with immunohistochemistry with monoclonal antibodies to a fast skeletal isoform of myosin heavy chain. RESULTS: Two months after intramyocardial grafting, tissue Doppler imaging and conventional echocardiographic assessment of the groups showed a marked improvement in the non-cultured cell therapy group. Ejection fraction (EF) (p<0.05) as well as systolic endocardial velocities (p<0.01) improved versus the placebo group. CmDiI and skeletal myosin heavy chain expression was detected in all animals at 2 months after implantation confirming engraftment of skeletal muscle cells. CONCLUSIONS: In conclusion, our data indicate that non-cultured muscle cell transplantation is feasible and may translate into a functional benefit in an ovine model of dilated heart failure. 相似文献
6.
D Kurtak H Jamnback R Meyer M Ocran P Renaud 《Journal of the American Mosquito Control Association》1987,3(2):201-210
The Onchocerciasis Control Program of the World Health Organization is carrying out an extensive screening program in a search for new larvicides to be used for control of Simulium damnosum s.l. Emphasis has been given to finding a pyrethroid and a carbamate to supplement the organophosphates currently in use. These chemicals with differing modes of action, together with Bacillus thuringiensis H-14, are being used in an attempt to cope with the development and spread of resistance to the organophosphates temephos and chlorphoxim. 相似文献
7.
Functional signatures of protective antiviral T-cell immunity in human virus infections 总被引:9,自引:0,他引:9
Alexandre Harari Valérie Dutoit Cristina Cellerai Pierre-Alexandre Bart Renaud A. Du Pasquier & Giuseppe Pantaleo 《Immunological reviews》2006,211(1):236-254
Summary: The most common human viruses have different abilities to establish persistent chronic infection. Virus‐specific T‐cell responses are critical in the control of virus replication and in the prevention of disease in chronic infection. A large number of phenotypic markers and a series of functions have been used to characterize virus‐specific CD4+ and CD8+ T‐cell responses, and these studies have shown great phenotypic and functional heterogeneity of the T‐cell responses against different viruses. The heterogeneity of the T‐cell response has been proposed to be specific to each virus. However, over the past 2 years, several studies have provided evidence that the phenotypic and functional heterogeneity of CD4+ and CD8+ T‐cell responses is predominantly regulated by the levels of antigen load. The levels of antigen load modulate the phenotypic and functional patterns of the T‐cell response within the same virus infection. Furthermore, the functional characterization of virus‐specific CD4+ and CD8+ T‐cell responses has identified signatures of protective antiviral immunity. Polyfunctional, i.e. interleukin‐2 and interferon‐γ (IFN‐γ) secretion and proliferation, and not monofunctional, i.e. IFN‐γ secretion, CD4+ and CD8+ T‐cell responses represent correlates of protective antiviral immunity in chronic virus infections. 相似文献
8.
9.
O'Brien SG Guilhot F Larson RA Gathmann I Baccarani M Cervantes F Cornelissen JJ Fischer T Hochhaus A Hughes T Lechner K Nielsen JL Rousselot P Reiffers J Saglio G Shepherd J Simonsson B Gratwohl A Goldman JM Kantarjian H Taylor K Verhoef G Bolton AE Capdeville R Druker BJ;IRIS Investigators 《The New England journal of medicine》2003,348(11):994-1004
10.
Multicenter evaluation of the updated and extended API (RAPID) Coryne database 2.0. 总被引:6,自引:4,他引:6 下载免费PDF全文
In a multicenter study, 407 strains of coryneform bacteria were tested with the updated and extended API (RAPID) Coryne system with database 2.0 (bioMérieux, La-Balme-les-Grottes, France) in order to evaluate the system's capability of identifying these bacteria. The design of the system was exactly the same as for the previous API (RAPID) Coryne strip with database 1.0, i.e., the 20 biochemical reactions covered were identical, but database 2.0 included both more taxa and additional differential tests. Three hundred ninety strains tested belonged to the 49 taxa covered by database 2.0, and 17 strains belonged to taxa not covered. Overall, the system correctly identified 90.5% of the strains belonging to taxa included, with additional tests needed for correct identification for 55.1% of all strains tested. Only 5.6% of all strains were not identified, and 3.8% were misidentified. Identification problems were observed in particular for Corynebacterium coyleae, Propionibacterium acnes, and Aureobacterium spp. The numerical profiles and corresponding identification results for the taxa not covered by the new database 2.0 were also given. In comparison to the results from published previous evaluations of the API (RAPID) Coryne database 1.0, more additional tests had to be performed with version 2.0 in order to completely identify the strains. This was the result of current changes in taxonomy and to provide for organisms described since the appearance of version 1.0. We conclude that the new API (RAPID) Coryne system 2.0 is a useful tool for identifying the diverse group of coryneform bacteria encountered in the routine clinical laboratory. 相似文献